Resources and Publications

The Potentially Deleterious Impacts of the President’s FY 2015 Budget on U.S. Life Sciences Industries

March 14, 2014
| Blogs & Op-eds

The President's FY 2015 budget request does not do enough to invest in innovation or to propose reforms to policies that hinder the competitiveness of key U.S. innovation industries. This is the case particularly with regard to three issues impacting U.S. life sciences industries: the budget's call for flat year-over-year funding for biomedical research at the National Institutes of Health (NIH), the budget’s call to provide only seven years of data exclusivity protection for novel biologic medicines, and the budget’s failure to repeal the self-destructive medical device tax that is contributing to the decimation of the U.S. medical device industry.

RELATED CONTENT: